Log In
Print this Print this

BKC 002

  Manage Alerts
Collapse Summary General Information
Company Boryung Pharmaceutical Co. Ltd.
DescriptionCombination of Kanarb and undisclosed small molecule
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationHypertension
Indication DetailsTreat hypertension
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today